1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
  3. EAAT
  4. EAAT4 Isoform

EAAT4

EAAT4 is a human aspartate/glutamate transporter predominantly expressed in the cerebellum and functions as a ligand-gated chloride channel[1]. Mechanistically, EAAT4 localizes mainly to Purkinje cell dendrites, forms parasagittal cerebellar compartments, and concentrates near synapses in dendritic membranes facing astroglia[2][3]. Compared with EAAT1-EAAT3, EAAT4 shows high-affinity, low-capacity glutamate transport, slower kinetics, and distinct voltage dependence, supporting a role in binding residual extracellular glutamate rather than rapid bulk uptake[4]. In cerebellar models, EAAT4 shapes mGluR signaling, controls synaptic plasticity, and limits transmitter diffusion from climbing fibers[5][6]. Loss-of-function studies show that EAAT4 loss alters Purkinje cell firing and survival, distinguishing neuronal EAAT4 from glial GLAST/EAAT1 in cerebellar disease-relevant mechanisms[7]. For experimental applications, TBOA inhibits EAAT4 currents and can help test transporter-dependent glutamate uptake and anion conductance in heterologous or cerebellar preparations[4].- EAAT4 links glutamate clearance, chloride conductance, and Purkinje cell compartmental signaling.- EAAT4 differs from EAAT1-EAAT3 by slower, high-affinity, low-capacity transport kinetics.- TBOA-based inhibition supports functional testing of EAAT4-dependent glutamate uptake mechanisms.

References:

EAAT4 Related Products (2):

Cat. No. Product Name Effect Purity
  • HY-130125
    SLC1A1/EAAT3-IN-1
    Inhibitor 98.63%
    SLC1A1/EAAT3-IN-1 (Compound 3e) is a selective EAAT3 inhibitor with an IC50 of 7.2  μM for hEAAT3 over EAAT1,2,4 (IC50: ∼ 250 μM). SLC1A1/EAAT3-IN-1 can be used for psychiatric disorders such as obsessive compulsive disorder and schizophrenia research.
  • HY-101227
    (±)-threo-3-Methylglutamic acid
    Inhibitor
    (±)-threo-3-Methylglutamic acid is a potent EAAT2/4 inhibitor. (±)-threo-3-Methylglutamic acid also is an ionotropic glutamate receptor agonist. (±)-threo-3-Methylglutamic acid inhibits glutamate uptake by rod outer segments.